Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects

European Journal of Clinical Investigation

Volumn 31, Issue 4, 2001, Pages 285-292

  Prohaszka Z ^a,b   Duba, J ^c   Horvath L ^a,b   Csaszar A ^a   Karadi I ^a,b   Szebeni, A ^a   Singh, M ^d   Fekete, B ^a,b   Romics, L ^a,b   Fust G ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c National Institute of Cardiology Budapest   (Hungary)

^d LIONEX DIAGNOSTICS AND THERAPEUTICS GMBH   (Germany)

Author keywords

Antibodies; Coronary heart disease; Heat shock protein 60; Mycobacterium bovis hsp65

Indexed keywords

AUTOANTIBODY; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; COMPLEMENT; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 65; PROTEIN ANTIBODY;

ADULT; ANGIOCARDIOGRAPHY; ANTIBODY BLOOD LEVEL; ANTIGEN SPECIFICITY; ARTICLE; ATHEROSCLEROSIS; BYPASS SURGERY; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM BOVIS; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ADULT; AGE FACTORS; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; AUTOANTIBODIES; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; CHAPERONIN 60; CORONARY DISEASE; CROSS REACTIONS; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MOLECULAR WEIGHT; RISK FACTORS; SEX FACTORS;

EID: 0035063762     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2001.00819.x     Document Type: Article

References (36)

1. Biology of disease. Involvement of the immune system in human atherosclerosis: Current knowledge and unanswered questions
2. Atherosclerosis - An inflammatory disease
3. Association of serum antibodies to heat-shock protein 65 with acrotid atherosclerosis. Clinical significance determined in a follow-up study
4. Is atherosclerosis an immunologically mediated disease?
5. Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue
6. The role of heat shock proteins in protection and pathophysiology of the arterial wall
7. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis
8. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity
9. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction
10. Anti-heat shock protein 65 titers in acute myocardial infarction
11. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk
12. Association of antibodies to heat-shock protein 65 with percutaneous transluminal coronary angioplasty and subsequent restenosis
13. Antibodies against human hsp60 and mycobacterial hsp65 differ in their antigen specificity and complement activating ability
14. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae. Immune reactions to heat shock proteins as a possible link between infection and atherosclerosis
15. Autoimmunity, microbial immunity and the immunological homunculus
16. Epitope specificity of anti-heat shock protein 65/60 serum antibodies in atherosclerosis
17. Autoantibodies to human heat shock protein (hsp) 60 may be induced by Escherichia coli groEL
18. Antibody response to B cell epitopes of Chlamydia trachomatis 60-kDa heat-shock protein and corresponding mycobacterial and human peptides in infants with chlamydial pneumonitis
19. Continuous B-cell epitopes in Chlamydia trachomatis heat-shock protein 60
20. Selective coronary angiography: Part I: Percutaneous transfemoral approach
21. Antibodies against 60kD: Heat-shock proteins in human immunodeficiency virus infection
22. + T cell subsets according to their expression of CD45 isotypes
23. Atherosclerosis - An autoimmune disease
24. Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins
25. Suppressive effect of anti-inflammatory agents on human endotheial cell activation and induction of heat shock proteins
26. Processes in atherogenesis: Complement activation
27. Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation
28. Immunohistochemical colocalization of the terminal complex of human complement and smooth muscle cell α-actin in early atherosclerotic lesions
29. Immunohistochemical demonstration of enzymatically modified human LDL and its cloclaization with the terminal complement complex in the early atherosclerotic lesion
30. C-reactive protein frequently colocalizes with the terminal complex in the intima of early atherosclerotic lesions of human coronary arteries
31. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population
32. Independent and joint effects of antibodies to human heat-shock protein 60 and chlamydia pneumoniae infection in the development of coronary atherosclerosis
33. Analysis of the normal human IgG antibody repertoire. Evidence that IgG autonatibodies of healthy adults recognize a limited and conserved set of protein antigens in homologous tissues
34. Invariance and restriction towards a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults
35. Innate natural antibodies. Primary roles indicated by specific epitopes
36. Stability of natural self-reactive antibody repertoires during aging